Human listeriosis caused by Listeria ivanovii.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMC 2874378)

Published in Emerg Infect Dis on January 01, 2010

Authors

Christelle Guillet1, Olivier Join-Lambert, Alban Le Monnier, Alexandre Leclercq, Frédéric Mechaï, Marie France Mamzer-Bruneel, Magdalena K Bielecka, Mariela Scortti, Olivier Disson, Patrick Berche, Jose Vazquez-Boland, Olivier Lortholary, Marc Lecuit

Author Affiliations

1: Universite Paris Descartes, Paris, France.

Articles citing this

Comparative analysis of plasmids in the genus Listeria. PLoS One (2010) 1.22

Laboratory diagnosis of bacterial gastroenteritis. Clin Microbiol Rev (2015) 1.03

Targeting of the central nervous system by Listeria monocytogenes. Virulence (2012) 1.01

Development and validation of qualitative SYBR®Green real-time PCR for detection and discrimination of Listeria spp. and Listeria monocytogenes. Appl Microbiol Biotechnol (2012) 0.89

Defensins from the tick Ixodes scapularis are effective against phytopathogenic fungi and the human bacterial pathogen Listeria grayi. Parasit Vectors (2014) 0.87

Development of a novel selective and differential medium for the isolation of Listeria monocytogenes. Appl Environ Microbiol (2013) 0.84

Highly specific fiber optic immunosensor coupled with immunomagnetic separation for detection of low levels of Listeria monocytogenes and L. ivanovii. BMC Microbiol (2012) 0.84

Identification of Surface Protein Biomarkers of Listeria monocytogenes via Bioinformatics and Antibody-Based Protein Detection Tools. Appl Environ Microbiol (2016) 0.83

Characteristics and distribution of Listeria spp., including Listeria species newly described since 2009. Appl Microbiol Biotechnol (2016) 0.83

Complete genome sequence of the animal pathogen Listeria ivanovii, which provides insights into host specificities and evolution of the genus Listeria. J Bacteriol (2011) 0.81

Rapid and sensitive detection of Listeria ivanovii by loop-mediated isothermal amplification of the smcL gene. PLoS One (2014) 0.80

Comparison of the Prevalences and Diversities of Listeria Species and Listeria monocytogenes in an Urban and a Rural Agricultural Watershed. Appl Environ Microbiol (2015) 0.80

Evaluation of the anti-Listeria potentials of some plant-derived triterpenes. Ann Clin Microbiol Antimicrob (2014) 0.78

Biofilm formation and adherence characteristics of Listeria ivanovii strains isolated from ready-to-eat foods in Alice, South Africa. ScientificWorldJournal (2012) 0.78

Genotypic characterization of Listeria monocytogenes isolated from humans in India. Ann Trop Med Parasitol (2011) 0.78

Current status of antibiograms of Listeria ivanovii and Enterobacter cloacae isolated from ready-to-eat foods in Alice, South Africa. Int J Environ Res Public Health (2012) 0.77

Listeriosis outbreaks in British Columbia, Canada, caused by soft ripened cheese contaminated from environmental sources. Biomed Res Int (2015) 0.76

Development of new multilocus variable number of tandem repeat analysis (MLVA) for Listeria innocua and its application in a food processing plant. PLoS One (2014) 0.75

Occurrence, Persistence, and Virulence Potential of Listeria ivanovii in Foods and Food Processing Environments in the Republic of Ireland. Biomed Res Int (2015) 0.75

Fructose 1,6-Bisphosphate Aldolase, a Novel Immunogenic Surface Protein on Listeria Species. PLoS One (2016) 0.75

Identification of Listeria Spp. Strains Isolated from Meat Products and Meat Production Plants by Multiplex Polymerase Chain Reaction. Ital J Food Saf (2015) 0.75

Foodborne Listeria monocytogenes: A Real Challenge in Quality Control. Scientifica (Cairo) (2016) 0.75

Molecular approaches to the identification of pathogenic and nonpathogenic listeriae. Microbiol Insights (2013) 0.75

In vitro anti-listerial activities of crude n-hexane and aqueous extracts of Garcinia kola (heckel) seeds. Int J Mol Sci (2011) 0.75

Development of ListeriaBase and comparative analysis of Listeria monocytogenes. BMC Genomics (2015) 0.75

Genome analysis of Listeria ivanovii strain G770 that caused a deadly aortic prosthesis infection. New Microbes New Infect (2016) 0.75

Antagonistic Effect of Pseudomonas sp. CMI-1 on
Foodborne Pathogenic Listeria monocytogenes. Food Technol Biotechnol (2015) 0.75

Bacteriocins synthesized by Bacillus thuringiensis: generalities and potential applications. Rev Med Microbiol (2016) 0.75

Listeria ivanovii Infection in Mice: Restricted to the Liver and Lung with Limited Replication in the Spleen. Front Microbiol (2016) 0.75

Contamination Levels and Identification of Bacteria in Milk Sampled from Three Regions of Tanzania: Evidence from Literature and Laboratory Analyses. Vet Med Int (2017) 0.75

Analysis of Listeria using exogenous volatile organic compound metabolites and their detection by static headspace-multi-capillary column-gas chromatography-ion mobility spectrometry (SHS-MCC-GC-IMS). Anal Bioanal Chem (2017) 0.75

Articles cited by this

Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev (2001) 10.41

An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk. N Engl J Med (1997) 4.33

A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J (1999) 3.29

[Distribution of species of the genus Listeria]. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.76

Glucose-1-phosphate utilization by Listeria monocytogenes is PrfA dependent and coordinately expressed with virulence factors. J Bacteriol (1997) 1.53

Listeria ivanovii infection in a patient with AIDS. J Infect (1994) 1.27

Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect (2000) 1.16

Listeria ivanovii infection. J Infect (1994) 1.15

Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. Nat Med (2006) 1.12

A spontaneous genomic deletion in Listeria ivanovii identifies LIPI-2, a species-specific pathogenicity island encoding sphingomyelinase and numerous internalins. Mol Microbiol (2006) 1.09

Human listeriosis in the United States, 1967-1969. J Infect Dis (1971) 1.08

Low virulence but potentially fatal outcome-Listeria ivanovii. Eur J Intern Med (2006) 1.04

Occurrence of Listeria monocytogenes and other Listeria spp. in raw caprine milk. J Dairy Sci (1996) 0.88

[Isolation of Listeria ivanovii in Slovakia]. Cesk Epidemiol Mikrobiol Imunol (1990) 0.84

Articles by these authors

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis (2008) 20.88

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med (2002) 17.04

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis (2010) 11.65

Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 9.54

The Listeria transcriptional landscape from saprophytism to virulence. Nature (2009) 5.88

Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis (2012) 5.66

Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med (2015) 5.16

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis (2007) 5.15

Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med (2004) 4.47

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis (2006) 4.42

Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85

A new perspective on Listeria monocytogenes evolution. PLoS Pathog (2008) 3.85

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med (2011) 3.63

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog (2008) 3.40

Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe (2010) 3.39

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet (2007) 3.11

Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis (2010) 3.07

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med (2009) 3.07

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol (2009) 2.94

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med (2007) 2.85

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol (2008) 2.82

Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol Microbiol (2002) 2.70

Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis (2012) 2.68

Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2010) 2.67

Systemic antifungal therapy in critically ill patients without invasive fungal infection*. Crit Care Med (2012) 2.55

Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis (2009) 2.54

Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics (2008) 2.51

Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med (2008) 2.49

A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc Natl Acad Sci U S A (2007) 2.46

Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis (2009) 2.33

Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr (2007) 2.32

Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis (2002) 2.20

Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis (2003) 2.19

Hpt, a bacterial homolog of the microsomal glucose- 6-phosphate translocase, mediates rapid intracellular proliferation in Listeria. Proc Natl Acad Sci U S A (2001) 2.19

Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol (2002) 2.15

Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS (2004) 2.11

Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood (2006) 2.06

Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions. Trends Cell Biol (2003) 2.04

Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J Bacteriol (2002) 1.99

Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol (2006) 1.96

Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2007) 1.95

Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature (2008) 1.90

Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis (2013) 1.86

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86

Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. Am J Respir Crit Care Med (2003) 1.85

Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol (2005) 1.83

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA (2011) 1.83

Identification of the first human gyrovirus, a virus related to chicken anemia virus. J Virol (2011) 1.81

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica (2012) 1.80

Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol (2005) 1.80

Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. J Clin Microbiol (2002) 1.79

A molecular marker for evaluating the pathogenic potential of foodborne Listeria monocytogenes. J Infect Dis (2004) 1.78

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78

Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol (2011) 1.76

Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients. Br J Haematol (2002) 1.76

Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells. EMBO J (2011) 1.74

Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis (2003) 1.74

Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4. Blood (2009) 1.74

Increasing incidence of listeriosis in France and other European countries. Emerg Infect Dis (2008) 1.74

Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol (2011) 1.64

Worldwide distribution of major clones of Listeria monocytogenes. Emerg Infect Dis (2011) 1.64

Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerg Infect Dis (2007) 1.63

Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62

Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60

Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children. J Microbiol Methods (2006) 1.59

Fusobacterium necrophorum middle ear infections in children and related complications: report of 25 cases and literature review. Pediatr Infect Dis J (2008) 1.59

β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis (2011) 1.56

Fungal infections in immunocompromised travelers. Clin Infect Dis (2012) 1.53

Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis (2006) 1.53

Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study. J Infect (2013) 1.52

The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med (2010) 1.51

Gp96 is a receptor for a novel Listeria monocytogenes virulence factor, Vip, a surface protein. EMBO J (2005) 1.49

LPXTG protein InlJ, a newly identified internalin involved in Listeria monocytogenes virulence. Infect Immun (2005) 1.48

Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg Infect Dis (2012) 1.47

Identification of the agr locus of Listeria monocytogenes: role in bacterial virulence. Infect Immun (2003) 1.47

The sortase SrtA of Listeria monocytogenes is involved in processing of internalin and in virulence. Infect Immun (2002) 1.46

Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak. PLoS One (2009) 1.46

Ocular adnexal lymphoma and Helicobacter pylori gastric infection. Am J Hematol (2010) 1.45

Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis (2012) 1.45

Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis (2008) 1.44

Chikungunya virus infection of corneal grafts. J Infect Dis (2012) 1.44

Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS One (2008) 1.43

Healthcare-associated mucormycosis. Clin Infect Dis (2012) 1.42

Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2010) 1.41

Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis (2012) 1.41

Impact of lactobacilli on orally acquired listeriosis. Proc Natl Acad Sci U S A (2012) 1.38

Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med (2011) 1.36

Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg Infect Dis (2011) 1.36

Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.34

Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults. Antimicrob Agents Chemother (2009) 1.34